Epidemiological Impact of Nirsevimab on Admissions for Bronchiolitis in a Pediatric Emergency Department: A Single-Center Cohort Study
= 0.021). Hospitalization rates remained stable, though absolute admissions were halved. In conclusion, nirsevimab immunization reduced RSV burden, supporting its inclusion in universal prevention programs and the need for multicenter prospective studies to assess long-term outcomes.
Authors
- Irene Tardivo
- Irene Raffaldi (ORCID: https://orcid.org/0000-0002-0147-6516)
- Rosanna Irene Comoretto (ORCID: https://orcid.org/0000-0002-8601-1899)
- Claudia Bondone (ORCID: https://orcid.org/0000-0003-4120-2533)
- Emanuele Castagno (ORCID: https://orcid.org/0000-0001-7756-5075)
- Franca Fagioli (ORCID: https://orcid.org/0000-0002-9257-900X)
- Lorenzo Milani (ORCID: https://orcid.org/0000-0002-2185-2179)
- Carola Aschieri
- Irene Ferri
- Sara El Khbazi
Institutions
- Ospedale Regina Margherita (IT)
- Department of Public Health (US)
- University of Turin (IT)
Publication Details
- Journal
- Viruses
- Published
- 2026-04-16
- DOI
- https://doi.org/10.3390/v18040469
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00